GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor Therapeutics, Inc. (HPPI) | 8/17/2026 8:01:04 AM | View | Proxy | SEC | Y 2025 | ||||||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/14/2026 4:13:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $637,190 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/15/2026 3:13:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $1,433,363 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/26/2026 6:13:11 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $2,511,307 | EPS -$0.02 | ||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/13/2025 11:42:36 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $3,135,167 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/13/2025 4:14:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $3,907,662 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/14/2025 9:15:31 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $4,505,267 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/28/2025 4:23:35 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $5,694,658 | EPS -$0.02 | ||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/12/2024 9:33:14 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $6,451,442 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/6/2024 9:46:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $7,173,367 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/13/2024 9:17:45 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $7,794,220 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/29/2024 4:17:07 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $8,949,155 | EPS -$0.02 | ||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/13/2023 9:15:27 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $9,607,689 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/11/2023 9:28:38 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $10,158,334 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/15/2023 9:11:38 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $10,835,189 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/31/2023 5:09:33 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $11,975,124 | EPS $0.03 | ||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/14/2022 4:37:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $63,117 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/12/2022 4:39:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $38,517 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/13/2022 9:17:07 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $61,143 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/30/2022 9:19:54 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $58,784 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/12/2021 9:11:38 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $92,518 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/13/2021 9:13:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $136,520 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/14/2021 9:11:59 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $138,066 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/26/2021 9:13:41 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $131,759 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/16/2020 9:16:24 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $103,730 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 8/12/2020 9:16:05 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $216,400 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 5/1/2020 9:20:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $397,304 | |||
| Inhibitor Therapeutics, Inc. (HPPI) | 3/30/2020 9:16:31 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $899,966 | EPS -$0.01 | ||
| Inhibitor Therapeutics, Inc. (HPPI) | 12/5/2019 5:11:42 PM | View | Proxy | SEC | Y 2018 | ||||||
| Inhibitor Therapeutics, Inc. (HPPI) | 11/7/2019 5:01:46 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $1,483,869 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 8/12/2019 4:51:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $2,131,553 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 6/3/2019 4:35:07 PM | View | Proxy | SEC | Y 2018 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/9/2019 9:21:53 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $1,252,545 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 3/7/2019 9:19:36 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $14,027 | Assets $1,233,001 | EPS -$0.01 | |
| HedgePath Pharmaceuticals, Inc. (HPPI) | 1/8/2019 5:18:39 PM | View | Proxy | SEC | Y 2018 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 12/21/2018 8:32:40 AM | View | Proxy | SEC | Y 2017 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 11/14/2018 9:16:03 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $3,995 +91.5% | Assets $1,832,582 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 7/23/2018 9:11:13 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $2,490 -16.9% | Assets $1,184,453 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/1/2018 8:45:33 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $4,222 -63.7% | Assets $1,979,610 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 2/16/2018 8:17:00 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $768,052 | EPS -$0.01 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 11/13/2017 6:22:37 AM | View | Proxy | SEC | Y 2016 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 10/31/2017 9:16:38 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $2,086 | Assets $1,308,922 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 7/31/2017 10:22:44 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $2,995 | Assets $2,061,315 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/8/2017 9:12:19 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $11,645 | Assets $2,775,108 | EPS -$0.01 | |
| HedgePath Pharmaceuticals, Inc. (HPPI) | 2/17/2017 4:31:47 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $7,338,095 | EPS -$0.02 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 10/31/2016 8:00:47 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $3,862,736 | EPS -$0.01 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 8/12/2016 8:01:41 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $4,915,294 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/13/2016 9:01:58 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $420,640 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 2/1/2016 4:01:30 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $885,859 | EPS -$0.02 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 11/4/2015 8:01:20 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $1,549,883 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 8/14/2015 4:08:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $2,189,846 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 6/16/2015 4:01:09 PM | View | Proxy | SEC | Y 2014 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/13/2015 9:00:50 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $127,674 | |||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 2/13/2015 4:44:58 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $462,978 | EPS -$0.04 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 10/14/2014 4:51:37 PM | View | Proxy | SEC | Y 2013 | ||||||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 10/10/2014 4:11:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $423,105 | EPS -$0.01 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 8/13/2014 4:34:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $300,517 | EPS -$0.10 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 5/12/2014 4:03:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $10,456 | EPS -$0.01 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 4/15/2014 4:11:54 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $10,217 | EPS -$0.10 | ||
| HedgePath Pharmaceuticals, Inc. (HPPI) | 11/14/2013 4:31:24 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $112 | EPS -$0.07 | ||
| COMMONWEALTH BIOTECHNOLOGIES INC (HPPI) | 9/17/2009 1:56:52 PM | View | Proxy | SEC | Y 2008 |